Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	363.04M +221.3%
Revenue (ttm)	83.23M +153.6%
Net Income	-2.59M
EPS	-0.03
Shares Out	100.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,110
Open	3.960
Previous Close	3.930
Day's Range	3.630 - 3.960
52-Week Range	1.450 - 4.980
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 31
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 62.50 million, an increase of 105.02% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.